Specialty Pharmacy

An experimental ovarian cancer treatment failed to demonstrate statistically significant improvements in overall survival during a phase 3 trial.

With concerns of a potential Ebola outbreak in the United States still heightened, a pharmaceutical disaster response group is readying pharmacists with a series of resources on the virus.

An investigational HIV drug developed by Merck exhibited a strong overall safety and efficacy profile in a recently completed phase 2b study.

The severe respiratory illness that infected more than 1000 children across the United States is starting to wane.

QmedRx Vice President of Formulations Scott Karolchyk discusses the resurgence of compounding pharmacies.

Astellas today announced that the FDA has granted orphan drug designation to isavuconazole for the treatment of invasive candidiasis, one of the most frequent invasive fungal infections detected in critically ill patients and a common cause of bloodstream infections.

One of the most crucial roles in the fight to stop the spread of Ebola may be played by a mouse.

T-cell immunotherapy enables stem cell transplants using partially mismatched family members as donors.

When examining the future of the Ebola virus, it is important to understand the epidemic in the context of similar outbreaks that occurred in the relatively recent past.

Discovery offers potential target for future HIV treatments.

Program can help pharmacies better secure their networks to minimize the risk of network attacks.

Patients with early stage tumors fare worse with erlotinib than if they take nothing.

Transmission of the Ebola virus remains widespread in West Africa, with infections among health care workers continuing to rise.

Bortezomib found to effectively treat chronic graft-versus-host disease.

Paul Jardina brings more than 20 years of health care industry experience to Onco360.

The World Health Organization convened a high-level emergency meeting with government leaders and pharmaceutical company representatives earlier this week to discuss issues surrounding access to experimental Ebola vaccines.

Methotrexate injection treats patients with rheumatoid arthritis, polyarticular-course juvenile idiopathic arthritis, and psoriasis.

Michael Nameth, RPh, MBA, chief executive officer of Aureus Health Services discusses the future path of the company.

New recommendations for the removal of protective gear highlight the need for enhanced technologies.

Sovriad found to have caused significant increase in blood bilirubin levels in deceased patients.

A dendritic cell vaccine for MS attacks the condition early, while preserving the immune system.

A perceived increase in confirmed cases of enterovirus D68 may be attributable to a faster lab test recently put in place by the US Centers for Disease Control and Prevention.

Study finds practices in less competitive markets are able to charge more for services.

Researchers investigate link between a child's genetic makeup and RA risk for mothers.

Federal officials are questioning state policies that mandate a 21-day quarantine of health care workers who treat Ebola patients.

The FDA today granted breakthrough therapy designation to a new treatment for non-small cell lung cancer patients.

Esbriet was granted orphan drug designation and received priority review.

Nanotechnology and shortwave infrared light reveals small tumors and cardiovascular lesions deep inside body.

Hexavalent vaccine protects against diphtheria, tetanus, pertussis, polio, invasive disease caused by Haemophilus influenzae type b, and hepatitis B.